Quarterly report pursuant to Section 13 or 15(d)

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS - RESTATED CONSOLIDATED STATEMENTS OF OPERATIONS (Details)

v3.24.3
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS - RESTATED CONSOLIDATED STATEMENTS OF OPERATIONS (Details) - USD ($)
 3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
OPERATING EXPENSES:    
Research and development $ 7,088,042 $ 6,359,256
General and administrative 4,913,444 2,346,045
Total operating expenses 12,001,486 8,705,301
LOSS FROM OPERATIONS (12,001,486) (8,705,301)
OTHER INCOME (EXPENSE):    
(Loss) gain on valuation of warrants (14,960,346) 1,390,797
Interest income 319,849 124,034
Total other (expense) income, net (14,640,497) 1,514,831
NET LOSS $ (26,641,983) $ (7,190,470)
BASIC NET LOSS PER SHARE $ (0.91) $ (0.64)
DILUTED NET LOSS PER SHARE $ (0.91) $ (0.64)
BASIC WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING 29,346,679 11,261,217
DILUTED WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING 29,346,679 11,261,217
As previously reported    
OPERATING EXPENSES:    
Research and development $ 7,377,940  
General and administrative 4,623,546  
Total operating expenses 12,001,486  
LOSS FROM OPERATIONS (12,001,486)  
OTHER INCOME (EXPENSE):    
(Loss) gain on valuation of warrants (9,900,000)  
Interest income 319,849  
Total other (expense) income, net (9,580,151)  
NET LOSS $ (21,581,637)  
BASIC NET LOSS PER SHARE $ (0.74)  
DILUTED NET LOSS PER SHARE $ (0.74)  
BASIC WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING 29,346,679  
DILUTED WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING 29,346,679  
Restatement adjustments    
OPERATING EXPENSES:    
Research and development $ (289,898)  
General and administrative 289,898  
OTHER INCOME (EXPENSE):    
(Loss) gain on valuation of warrants (5,060,346)  
Total other (expense) income, net (5,060,346)  
NET LOSS $ (5,060,346)  
BASIC NET LOSS PER SHARE $ (0.17)  
DILUTED NET LOSS PER SHARE $ (0.17)